আপনি WORLD360-এর বাংলা সংস্করণ পড়ছেন, যা এখনও তৈরি হচ্ছে। মেনু ও শিরোনাম বাংলায়; অনুবাদ তৈরি না হওয়া পর্যন্ত খবর ইংরেজিতে দেখা যাবে।

India

Government caps trade margin for 137 cancer drugs at 30%, prices likely to fall by up to 70%

India's regulator capped trade margins on 137 cancer drugs at 30% of MRP, aiming to slash prices by up to 70% and spark legal debate.

◆2টি স্বাধীন সূত্র◆3টি সূত্র-উপাদান◆heat 0.09◆আপডেট: 13m

Outlets are counted by registrable domain, so a broadcaster’s station subdomains count once. 1 of the 3 items repeat an outlet already counted.

ইঞ্জিনের মূল্যায়ন

India's regulator capped trade margins on 137 cancer drugs at 30% of MRP, aiming to slash prices by up to 70% and spark legal debate.

Trade margin cap set

The National Pharmaceutical Pricing Authority announced a 30% ceiling on the trade margin for 137 non‑scheduled anti‑cancer medicines. The cap applies to the margin that distributors, chemists and hospitals retain from the maximum retail price, excluding GST. The decision was approved in NPPA meetings on October 16 and 17 and will take effect on November 9.

How the cap is calculated

The authority will compute each drug's revised MRP using the price that manufacturers received from stockists in March 2026, adjusted for discounts and total units sold. If a drug had no sales in that month, data from April 2025 to March 2026 will be used, and sales to government buyers are omitted. The 30% margin translates to a 42.86% markup on the price to the distributor, meaning a product sold to a distributor for ₹100 can carry an MRP of about ₹143 before GST.

Supreme Court raises concerns

During a hearing on October 12, a Supreme Court bench questioned why the 30% trade‑margin restriction was limited to cancer drugs and not extended to other essential medicines or medical devices. Justices noted that some mark‑ups on cancer drugs reach 1,000%, describing them as “broad daylight dacoity” that burdens patients. The court suggested that the broader 16% retailer margin under the Drugs (Prices Control) Order could also be applied to other products, signaling potential future regulatory expansion.

Coverage

2 independent outlets filed 3 reports over 11 hours.

2outlets
3filings
11hspan
singletrend
What could happen next
No outcome sealed yet.the engine has not sealed a forecast on this story yet. The forecast is always written to the ledger before any article about it, never the other way round.
প্রমাণ3 items
Government caps trade margin for 137 cancer drugs at 30%, prices likely to fall by up to 70%

The decision was approved at NPPA meetings on October 16 and 17, according to the minutes, seen by HT.

Government college teachers to protest against new pension scheme on October 15

They oppose the government’s decision to restrict interim pension for employees with 10 to 18 years of service to ₹10,000

Supreme Court wants cap on trade margin for all essential medicines and medical products

Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients

Sources are evidence, not content. Each keeps its own name, its own link and an extract capped at 400 characters; none of it is rewritten into the copy above.

ভারত বিভাগে আরও
1/8All →